These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3831730)

  • 41. [On the behavior of serum immunoglobulins in polytransfused thalassemic children].
    Di Tullio MT; Perrone L; Lama G
    Pediatria (Napoli); 1973 Oct; 81(3):434-7. PubMed ID: 4767792
    [No Abstract]   [Full Text] [Related]  

  • 42. Redesigning supply chain management together with the hospitals.
    Rautonen J
    Transfusion; 2007 Aug; 47(2 Suppl):197S-200S; discussion 201S. PubMed ID: 17651350
    [No Abstract]   [Full Text] [Related]  

  • 43. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece.
    Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA
    Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791
    [No Abstract]   [Full Text] [Related]  

  • 44. [Developments in blood transfusion].
    Krusius T; Porkka K
    Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
    [No Abstract]   [Full Text] [Related]  

  • 45. [Investigation of immunoconglutinin in beta-thalassemic patients after multiple transfusions].
    Govoni F; Govoni M
    Riv Emoter Immunoematol; 1983; 30(3):282-7. PubMed ID: 6669877
    [No Abstract]   [Full Text] [Related]  

  • 46. Blood transfusion in Bangladesh with particular emphasis on the treatment of Thalassemia patients.
    Islam MB
    Transfus Apher Sci; 2013 Aug; 49(1):3-4. PubMed ID: 23916541
    [No Abstract]   [Full Text] [Related]  

  • 47. [Modern therapeutic possibilities in Cooley's disease].
    Carcassi U
    Atti Accad Fisiocrit Siena Med Fis; 1966; 15(2):1105-31. PubMed ID: 6001538
    [No Abstract]   [Full Text] [Related]  

  • 48. The multitransfused beta-thalassemic child: a model for the study of IgE response.
    Vierucci A; De Martino M; Di Palma A; Novembre E; Rossi ME; Resti M; Azzari C
    Ann Allergy; 1986 Feb; 56(2):158-61. PubMed ID: 3946850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Preparation and transfusion of blood components within the framework of a hospital blood donor service].
    Matthes M; Kleine N; Engbring H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(2):173-7. PubMed ID: 4167548
    [No Abstract]   [Full Text] [Related]  

  • 50. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
    Karimi M; Nikrooz P; Kashef S; Jamalian N; Davatolhagh Z
    Int J Lab Hematol; 2007 Oct; 29(5):321-6. PubMed ID: 17824911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allogeneic marrow transplantation for thalassemia.
    Lucarelli G; Polchi P; Izzi T; Manna M; Agostinelli F; Delfini C; Porcellini A; Galimberti M; Moretti L; Manna A
    Exp Hematol; 1984 Sep; 12(8):676-81. PubMed ID: 6386507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
    Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract]   [Full Text] [Related]  

  • 53. [Long-term results of splenectomy in thalassemia major].
    Alamanni F; Gallisai D; Maniga AM; Bacciu PP; Noya G; Frassetto GA; Dettori G; Biglioli P
    Minerva Chir; 1983 May; 38(10):693-6. PubMed ID: 6877629
    [No Abstract]   [Full Text] [Related]  

  • 54. Therapy of HBsAg-negative chronic active hepatitis in transfusion-dependent thalassemia major.
    De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Ferreli A; Cao A
    Birth Defects Orig Artic Ser; 1982; 18(7):355-60. PubMed ID: 6819018
    [No Abstract]   [Full Text] [Related]  

  • 55. The management of the improved prognosis in thalassemia major.
    Modell B
    Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016
    [No Abstract]   [Full Text] [Related]  

  • 56. Haptoglobin status in thalassemia.
    Tharthare MK; Baxi AJ; Chengappa D
    Indian Pediatr; 1984 Mar; 21(3):223-7. PubMed ID: 6490143
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the dynamics of the blood platelets in polytransfused subjects of pediatric age].
    Mensi E
    Minerva Nipiol; 1968; 18():Suppl 6:397+. PubMed ID: 5266942
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis].
    Orsini A; Giraud F; Bernard P; Passeron P
    Mars Med; 1965; 102(7):591-5. PubMed ID: 5855127
    [No Abstract]   [Full Text] [Related]  

  • 59. [Development of blood transfusion service in the Ivanovo district].
    Kulemin VV; Bachev VI; Samoilova NV
    Probl Gematol Pereliv Krovi; 1974 Feb; 19(2):62-3. PubMed ID: 4283129
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes.
    Berte LM; Dechristopher PJ
    MLO Med Lab Obs; 1996 Mar; 28(3):28-34. PubMed ID: 10156309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.